Results 251 to 260 of about 273,871 (338)

Stability and Mitochondrial Localization of a Highly Cytotoxic Organogold(III) Complex with Diphosphine Ancillary Ligand in Lung Cancer Cells

open access: yesAngewandte Chemie, EarlyView.
The combination of cryo‐synchrotron radiation‐X‐ray fluorescence (cryo‐SR‐XRF), cryo‐synchrotron radiation‐X‐ray absorption (cryo‐SR‐XAS) and high‐resolution mass spectrometry demonstrates the high intracellular stability of a biphenyl gold(III) diphosphine complex indicating the native organogold cation as the active species.
Hester Blommaert   +10 more
wiley   +2 more sources

Abnormal DNA Methylation Profile Suggests the Extension of the Clinical Spectrum of the SETD2‐Related Disorders to a Syndromic Multiple Tumor Phenotype

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT SETD2 has an essential role in epigenetic regulation. SETD2 pathogenic variants cause neurodevelopmental disorders (SETD2‐NDDs) that most commonly include various degrees of intellectual disability and behavioral disorders, macrocephaly, brain malformations, and generalized overgrowth.
Marie Lucain   +11 more
wiley   +1 more source

Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers

open access: yesAdvanced NanoBiomed Research, EarlyView.
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska   +2 more
wiley   +1 more source

Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis. [PDF]

open access: yesFront Oncol
Sayin SI   +9 more
europepmc   +1 more source

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

open access: yesAdvanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang   +4 more
wiley   +1 more source

Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy. [PDF]

open access: yesCancers (Basel)
Pathak GP   +7 more
europepmc   +1 more source

Evaluation of Biological Malignancy of Primary Lung Adenocarcinoma Using Two-Dimensional Polyacrylalnide Gel Electrophoresis.

open access: bronze, 2000
Takashi Hirano   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy